Cumberland Pharmaceuticals Inc. (CPIX): Price and Financial Metrics


Cumberland Pharmaceuticals Inc. (CPIX): $2.00

0.08 (+4.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CPIX Stock Summary

  • CUMBERLAND PHARMACEUTICALS INC's market capitalization of $27,639,170 is ahead of just 10.51% of US-listed equities.
  • The price/operating cash flow metric for CUMBERLAND PHARMACEUTICALS INC is higher than merely 15.88% of stocks in our set with a positive cash flow.
  • The volatility of CUMBERLAND PHARMACEUTICALS INC's share price is greater than that of just 19.4% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to CPIX, based on their financial statements, market capitalization, and price volatility, are MIND, AIN, GNRC, GIGA, and BODY.
  • Visit CPIX's SEC page to see the company's official filings. To visit the company's web site, go to www.cumberlandpharma.com.

CPIX Valuation Summary

  • In comparison to the median Healthcare stock, CPIX's price/sales ratio is 63.16% lower, now standing at 0.7.
  • Over the past 166 months, CPIX's price/sales ratio has gone down 7.5.

Below are key valuation metrics over time for CPIX.

Stock Date P/S P/B P/E EV/EBIT
CPIX 2023-03-17 0.7 0.8 -5.0 -5.9
CPIX 2023-03-16 0.8 0.9 -5.7 -6.7
CPIX 2023-03-15 0.7 0.8 -5.4 -6.3
CPIX 2023-03-14 0.7 0.9 -5.6 -6.6
CPIX 2023-03-13 0.7 0.9 -5.6 -6.6
CPIX 2023-03-10 0.8 0.8 -4.6 -4.6

CPIX Growth Metrics

    Its 2 year revenue growth rate is now at -16.69%.
  • Its year over year cash and equivalents growth rate is now at -30.72%.
  • The 4 year revenue growth rate now stands at 25.88%.
CPIX's revenue has moved up $6,282,347 over the prior 67 months.

The table below shows CPIX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 41.20713 6.775045 -6.977209
2022-06-30 37.8666 4.037711 -7.623848
2022-03-31 36.62293 4.406396 -5.059668
2021-12-31 35.98504 6.342443 -3.507587
2021-09-30 37.92672 5.236684 -0.543665
2021-06-30 39.10486 6.19576 0.029876

CPIX Price Target

For more insight on analysts targets of CPIX, see our CPIX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.50 Average Broker Recommendation 2 (Hold)

CPIX Stock Price Chart Interactive Chart >

Price chart for CPIX

CPIX Price/Volume Stats

Current price $2.00 52-week high $3.15
Prev. close $1.92 52-week low $1.89
Day low $1.91 Volume 43,698
Day high $2.09 Avg. volume 14,547
50-day MA $2.45 Dividend yield N/A
200-day MA $2.33 Market Cap 28.79M

Cumberland Pharmaceuticals Inc. (CPIX) Company Bio


Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States and internationally. The company was founded in 1999 and is based in Nashville, Tennessee.


CPIX Latest News Stream


Event/Time News Detail
Loading, please wait...

CPIX Latest Social Stream


Loading social stream, please wait...

View Full CPIX Social Stream

Latest CPIX News From Around the Web

Below are the latest news stories about CUMBERLAND PHARMACEUTICALS INC that investors may wish to consider to help them evaluate CPIX as an investment opportunity.

Q4 2022 Cumberland Pharmaceuticals Inc Earnings Call

Q4 2022 Cumberland Pharmaceuticals Inc Earnings Call

Yahoo | March 8, 2023

CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2022 financial results and provided a Company update. Net revenues grew 17% over the prior year to $42 million, resulting in $8 million in cash flow from operations.

Yahoo | March 7, 2023

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2022 FINANCIAL RESULTS

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2022 financial results and provide a company update after the market closes on Tuesday, March 7, 2023.

Yahoo | February 28, 2023

Cumberland Pharmaceuticals Third Quarter 2022 Earnings: US$0.028 loss per share (vs US$0.10 loss in 3Q 2021)

Cumberland Pharmaceuticals ( NASDAQ:CPIX ) Third Quarter 2022 Results Key Financial Results Revenue: US$11.4m (up 41...

Yahoo | November 11, 2022

Cumberland Pharmaceuticals Reports 41% Revenue Growth

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $11.4 million during the third quarter of 2022 - a 41% increase over the prior year period. Cumberland also reported a 19% increase in net revenues for the first nine months of the year compared to the same period in 2021.

Yahoo | November 8, 2022

Read More 'CPIX' Stories Here

CPIX Price Returns

1-mo -19.68%
3-mo -7.41%
6-mo -22.18%
1-year -27.27%
3-year -44.44%
5-year -70.63%
YTD -11.11%
2022 -51.82%
2021 58.31%
2020 -42.72%
2019 -14.59%
2018 -18.07%

Continue Researching CPIX

Here are a few links from around the web to help you further your research on Cumberland Pharmaceuticals Inc's stock as an investment opportunity:

Cumberland Pharmaceuticals Inc (CPIX) Stock Price | Nasdaq
Cumberland Pharmaceuticals Inc (CPIX) Stock Quote, History and News - Yahoo Finance
Cumberland Pharmaceuticals Inc (CPIX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8693 seconds.